The government’s message has quickly spread across social media platforms, with a hashtag—“The country’s calling you to drop those pounds”—topping trending topics and inspiring a wave of memes on ...

With more than half of Chinese adults now classified as overweight, health authorities are stepping up measures to get people ...

This includes the likes of Ozempic, Mounjaro, Saxenda and Wegovy, which can sell for up to £269 a month. The drugs have proved popular with overweight Brits who want to rapidly lose weight and ...

The Russian Embassy in Kenya seized the moment with a cheeky meme, highlighting the impact of Trump's tariffs. The popular meme depicts other countries "fighting", while Russia is shown "relaxing ...

AI-generated video published on Chinese TikTok accounts painted a glum picture of life in a re-industrialised America, with ...

Memes that mock Americans over Trump's tariffs have taken over Chinese social media. AI generated videos feature Trump and tech workers on the iPhone assembly line or sewing clothes. Scott Bessent ...

John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access to GLP-1 medications, such as Ozempic and Wegovy, for millions of Medicare ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

This was a mistake. These drugs, like Ozempic and Wegovy, can be a game changer.” Fetterman says he has lost 20 pounds and is not being paid for discussing his treatment. “I’m just a guy who ...

Behind the memes lies a deeper absurdity,' the video continued ... which produces blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, fell around five percent in Copenhagen. French ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...